Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats

Biomaterials

Volumn 34, Issue 34, 2013, Pages 8589-8598

  Thormann, Ulrich ^a,b   Ray, Seemun ^a   Sommer, Ursula ^a   ElKhassawna, Thaqif ^a   Rehling, Tanja ^a   Hundgeburth, Marvin ^a   Henß, Anja ^a   Rohnke, Marcus ^a   Janek, Jürgen ^a   Lips, Katrin S ^a   Heiss, Christian ^a,b   Schlewitz, Gudrun ^a,b   Szalay, Gabor ^a,b   Schumacher, Matthias ^c   Gelinsky, Michael ^c   Schnettler, Reinhard ^a,b   Alt, Volker ^a,b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Biomaterial; Bone; Calcium phosphate; Fracture; Strontium

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE CEMENT; DIFFERENT TREATMENTS; HISTOMORPHOMETRIC ANALYSIS; IMMUNOHISTOCHEMISTRY; OVARIECTOMIZED RATS; SPRAGUE-DAWLEY RATS; TIME OF FLIGHT SECONDARY ION MASS SPECTROMETRY;

BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; CALCIUM PHOSPHATE; FRACTURE; GENE EXPRESSION; PHOSPHATASES; RATS; SECONDARY ION MASS SPECTROMETRY; STRONTIUM;

DEFECTS;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENIC PROTEIN 2; CALCIUM; CALCIUM PHOSPHATE; CEMENT; COLLAGEN; OSTEOCALCIN; OSTEOPROTEGERIN; STRONTIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE PLATE; CONTROLLED STUDY; FEMALE; FEMUR; FEMUR FRACTURE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; METAPHYSEAL FRACTURE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOSYNTHESIS; OSTEOTOMY; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS;

BIOMATERIAL; BONE; CALCIUM PHOSPHATE; FRACTURE; STRONTIUM;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE CEMENTS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CALCIUM PHOSPHATES; ENDPOINT DETERMINATION; FEMALE; FEMUR; FRACTURES, BONE; IMMUNOHISTOCHEMISTRY; OSTEOCALCIN; OSTEOGENESIS; OSTEOPROTEGERIN; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; STRONTIUM;

EID: 84882909140     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.036     Document Type: Article

References (23)

1. Goldhahn J., Scheele W.H., Mitlak B.H., Abadie E., Aspenberg P., Augat P., et al. Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis. Bone 2008, 43:343-347.
2. Low K.L., Tan S.H., Zein S.H.S., Roether J.A., Mouriño V., Boccaccini A.R. Calcium phosphate-based composites as injectable bone substitute materials. JBiomed Mater Res B Appl Biomater 2010, 94:273-286.
3. Bonnelye E., Chabadel A., Saltel F., Jurdic P. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption invitro. Bone 2008, 42:129-138.
4. Marie P.J. Strontium ranelate: new insights into its dual mode of action. Bone 2007, 40:S5-S8.
5. Andersen O.Z., Offermanns V., Sillassen M., Almtoft K.P., Andersen I.H., Sørensen S., et al. Accelerated bone ingrowth by local delivery of strontium from surface functionalized titanium implants. Biomaterials 2013, 34:5883-5890.
6. Xin Y., Jiang J., Huo K., Hu T., Chu P.K. Bioactive srtio(3) nanotube arrays: strontium delivery platform on ti-based osteoporotic bone implants. ACS Nano 2009, 3:3228-3234.
7. Zhao L., Wang H., Huo K., Zhang X., Wang W., Zhang Y., et al. The osteogenic activity of strontium loaded titania nanotube arrays on titanium substrates. Biomaterials 2013, 34:19-29.
8. Park J.-W., Kim H.-K., Kim Y.-J., Jang J.-H., Song H., Hanawa T. Osteoblast response and osseointegration of a ti-6al-4v alloy implant incorporating strontium. Acta Biomater 2010, 6:2843-2851.
9. Park J.-W., Kim Y.-J., Jang J.-H. Enhanced osteoblast response to hydrophilic strontium and/or phosphate ions-incorporated titanium oxide surfaces. Clin Oral Implant Res 2010, 21:398-408.
10. Park J.-W., Kim Y.-J., Jang J.-H., Song H. Positive modulation of osteogenesis- and osteoclastogenesis-related gene expression with strontium-containing microstructured ti implants in rabbit cancellous bone. JBiomed Mater Res A 2013, 101:298-306.
11. Li Y., Li Q., Zhu S., Luo E., Li J., Feng G., et al. The effect of strontium-substituted hydroxyapatite coating on implant fixation in ovariectomized rats. Biomaterials 2010, 31:9006-9014.
12. Fu D.-L., Jiang Q.-H., He F.-M., Yang G.-L., Liu L. Fluorescence microscopic analysis of bone osseointegration of strontium-substituted hydroxyapatite implants. JZhejiang Univ Sci B 2012, 13:364-371.
13. Schumacher M., Henß A., Rohnke M., Gelinsky M. Anovel and easy-to-prepare strontium(II) modified calcium phosphate bone cement with enhanced mechanical properties. Acta Biomater 2013, 9:7536-7544.
14. Alt V., Thormann U., Ray S., Zahner D., Dürselen L., Lips K., et al. Anew metaphyseal bone defect model in osteoporotic rats to study biomaterials for the enhancement of bone healing in osteoporotic fractures. Acta Biomater 2013, 9:7035-7042.
15. Fletcher J.S., Vickerman J.C. Secondary ion mass spectrometry: characterizing complex samples in two and three dimensions. Anal Chem 2013, 85:610-639.
16. Vickerman J.C., Briggs D. ToF-SIMS: surface analysis by mass spectrometry 2001, IM, Chichester.
17. Heiss C., Govindarajan P., Schlewitz G., Hemdan N.Y.A., Schliefke N., Alt V., et al. Induction of osteoporosis with its influence on osteoporotic determinants and their interrelationships in rats by DEXA. Med Sci Monit 2012, 18:BR199-BR207.
18. Schlewitz G., Govindarajan P., Schliefke N., Alt V., Böcker W., Elkhassawna T., et al. Ovariectomy and calcium/vitamin D2/D3 deficient diet as a model of osteoporosis in the spine of sprague-dawley rats. ZOrthop Unfall 2013, 151:14-19.
19. Driessens F.C.M., De Maeyer E., Fernandez E., Boltong M., Berger G., Verbeeck R., et al. Amorphous calcium phosphate cements and their transformation into calcium deficient hydroxyapatite. Bioceramics 1996, 9:231-234.
20. Sanni O.D., Wagner M.S., Briggs D., Castner D.G., Vickerman J.C. Classification of adsorbed protein static tof-sims spectra by principal component analysis and neural networks. Surf Interface Anal 2002, 33:715-728.
21. Peters A., Toben D., Lienau J., Schell H., Bail H.J., Matziolis G., et al. Locally applied osteogenic predifferentiated progenitor cells are more effective than undifferentiated mesenchymal stem cells in the treatment of delayed bone healing. Tissue Eng Part A 2009, 15:2947-2954.
22. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (RESTa) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30:e36.
23. Vestermark M.T., Hauge E.-M., Soballe K., Bechtold J.E., Jakobsen T., Baas J. Strontium doping of bone graft extender. Acta Orthop 2011, 82:614-621.